Philipp Blanke, MD, a Jonathan R. Weir-McCall, MBCHB, PHD, b Stephan Achenbach, MD,
c Victoria Delgado, MD, PHD, d Jörg Hausleiter, MD, e Hasan Jilaihawi, MD, f Mohamed …

Transcatheter aortic valve implantation (TAVI) has matured into a standard treatment option
for patients with severe symptomatic aortic valve stenosis (AS) across the whole spectrum of …

Abstract Aims The Valve Academic Research Consortium (VARC), founded in 2010, was
intended to (i) identify appropriate clinical endpoints and (ii) standardize definitions of these …

Background Bicuspid aortic stenosis accounts for almost 50% of patients undergoing
surgical aortic valve replacement in the younger patients. Expanding the indication of …

Objectives The authors sought to prospectively determine the safety and efficacy of next-day
discharge using the Vancouver 3M (Multidisciplinary, Multimodality, but Minimalist) Clinical …

Importance Transcatheter aortic valve replacement (TAVR) is an effective treatment option
for high-risk patients with severe aortic stenosis. Different from surgery, transcatheter …

Abstract Background: The SAPIEN 3 (Edwards Lifesciences Inc., Irvine, California)
transcatheter valve incorporates features designed to address the well-known deficiencies …

Cardiac computed tomography (CT) was initially developed as a non-invasive diagnostic
tool to detect and quantify coronary stenosis. Thanks to the rapid technological …

Background: Delayed coronary obstruction (DCO) is an uncommon and barely reported
complication following transcatheter aortic valve replacement (TAVR). Objectives: The aim of …

Rationale: Calcific aortic stenosis (AS) is characterized by calcium deposition in valve
leaflets. However, women present lower aortic valve calcification loads than men for the …